ACCENDRA HEALTH INC (ACH) Fundamental Analysis & Valuation
NYSE:ACH • US6907321029
Current stock price
2.38 USD
+0.02 (+0.85%)
At close:
2.38 USD
0 (0%)
After Hours:
This ACH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ACH Profitability Analysis
1.1 Basic Checks
- ACH had positive earnings in the past year.
- In the past year ACH has reported a negative cash flow from operations.
- The reported net income has been mixed in the past 5 years: ACH reported negative net income in multiple years.
- Of the past 5 years ACH 4 years had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -44.89%, ACH is not doing good in the industry: 88.12% of the companies in the same industry are doing better.
- ACH's Return On Invested Capital of 6.54% is fine compared to the rest of the industry. ACH outperforms 65.35% of its industry peers.
- ACH had an Average Return On Invested Capital over the past 3 years of 5.25%. This is below the industry average of 8.98%.
- The last Return On Invested Capital (6.54%) for ACH is above the 3 year average (5.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.89% | ||
| ROE | N/A | ||
| ROIC | 6.54% |
ROA(3y)-17.83%
ROA(5y)-9.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.25%
ROIC(5y)6.87%
1.3 Margins
- Looking at the Operating Margin, with a value of 2.64%, ACH is in line with its industry, outperforming 53.47% of the companies in the same industry.
- In the last couple of years the Operating Margin of ACH has grown nicely.
- ACH's Gross Margin of 31.70% is fine compared to the rest of the industry. ACH outperforms 60.40% of its industry peers.
- ACH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.64% | ||
| PM (TTM) | N/A | ||
| GM | 31.7% |
OM growth 3Y31.87%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.52%
GM growth 5Y25.32%
2. ACH Health Analysis
2.1 Basic Checks
- ACH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, ACH has less shares outstanding
- ACH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ACH has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.32, we must say that ACH is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 1.32, ACH is not doing good in the industry: 61.39% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.32 |
ROIC/WACC1.03
WACC6.36%
2.3 Liquidity
- A Current Ratio of 0.58 indicates that ACH may have some problems paying its short term obligations.
- With a Current ratio value of 0.58, ACH is not doing good in the industry: 86.14% of the companies in the same industry are doing better.
- ACH has a Quick Ratio of 0.58. This is a bad value and indicates that ACH is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of ACH (0.50) is worse than 86.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.5 |
3. ACH Growth Analysis
3.1 Past
- ACH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.50%.
- Measured over the past years, ACH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.38% on average per year.
- Looking at the last year, ACH shows a very negative growth in Revenue. The Revenue has decreased by -55.89% in the last year.
- Measured over the past years, ACH shows a very negative growth in Revenue. The Revenue has been decreasing by -20.10% on average per year.
EPS 1Y (TTM)-37.5%
EPS 3Y-26.68%
EPS 5Y-15.38%
EPS Q2Q%-61.82%
Revenue 1Y (TTM)-55.89%
Revenue growth 3Y-34.78%
Revenue growth 5Y-20.1%
Sales Q2Q%-73.7%
3.2 Future
- ACH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.21% yearly.
- The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y-41.95%
EPS Next 2Y1.03%
EPS Next 3Y8.66%
EPS Next 5Y11.21%
Revenue Next Year-6.4%
Revenue Next 2Y-1.13%
Revenue Next 3Y1.12%
Revenue Next 5Y3.83%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ACH Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 2.51, the valuation of ACH can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of ACH indicates a rather cheap valuation: ACH is cheaper than 100.00% of the companies listed in the same industry.
- ACH is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 4.32, which indicates a rather cheap valuation of ACH.
- Based on the Price/Forward Earnings ratio, ACH is valued cheaper than 98.02% of the companies in the same industry.
- ACH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.51 | ||
| Fwd PE | 4.32 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ACH is valued cheaply inside the industry as 92.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.03%
EPS Next 3Y8.66%
5. ACH Dividend Analysis
5.1 Amount
- No dividends for ACH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ACH Fundamentals: All Metrics, Ratios and Statistics
2.38
+0.02 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19 2026-02-19/amc
Earnings (Next)05-06 2026-05-06/bmo
Inst Owners94.18%
Inst Owner Change0%
Ins Owners3%
Ins Owner Change30.94%
Market Cap181.93M
Revenue(TTM)4.72B
Net Income(TTM)-1.10B
Analysts50
Price Target3.32 (39.5%)
Short Float %11.13%
Short Ratio8.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.42%
Min EPS beat(2)-5.85%
Max EPS beat(2)6.69%
EPS beat(4)2
Avg EPS beat(4)2.81%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)6
Avg EPS beat(8)3.82%
EPS beat(12)10
Avg EPS beat(12)17.05%
EPS beat(16)12
Avg EPS beat(16)11.97%
Revenue beat(2)0
Avg Revenue beat(2)-20.47%
Min Revenue beat(2)-39.15%
Max Revenue beat(2)-1.79%
Revenue beat(4)0
Avg Revenue beat(4)-29.59%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-1.79%
Revenue beat(8)1
Avg Revenue beat(8)-14.92%
Revenue beat(12)3
Avg Revenue beat(12)-9.63%
Revenue beat(16)6
Avg Revenue beat(16)-6.83%
PT rev (1m)-12.16%
PT rev (3m)N/A
EPS NQ rev (1m)-169.99%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.75%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.51 | ||
| Fwd PE | 4.32 | ||
| P/S | 0.04 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.75 |
EPS(TTM)0.95
EY39.92%
EPS(NY)0.55
Fwd EY23.17%
FCF(TTM)-3.97
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS61.75
BVpS-6.03
TBVpS-23.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.89% | ||
| ROE | N/A | ||
| ROCE | 8.28% | ||
| ROIC | 6.54% | ||
| ROICexc | 8.05% | ||
| ROICexgc | N/A | ||
| OM | 2.64% | ||
| PM (TTM) | N/A | ||
| GM | 31.7% | ||
| FCFM | N/A |
ROA(3y)-17.83%
ROA(5y)-9.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.25%
ROIC(5y)6.87%
ROICexc(3y)5.93%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.65%
ROCE(5y)8.7%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y24.96%
ROICexc growth 5YN/A
OM growth 3Y31.87%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.52%
GM growth 5Y25.32%
F-Score3
Asset Turnover1.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.31 | ||
| Cap/Depr | 93.85% | ||
| Cap/Sales | 4.27% | ||
| Interest Coverage | 0.92 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.5 | ||
| Altman-Z | 1.32 |
F-Score3
WACC6.36%
ROIC/WACC1.03
Cap/Depr(3y)84.12%
Cap/Depr(5y)76.01%
Cap/Sales(3y)7.98%
Cap/Sales(5y)5.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y-26.68%
EPS 5Y-15.38%
EPS Q2Q%-61.82%
EPS Next Y-41.95%
EPS Next 2Y1.03%
EPS Next 3Y8.66%
EPS Next 5Y11.21%
Revenue 1Y (TTM)-55.89%
Revenue growth 3Y-34.78%
Revenue growth 5Y-20.1%
Sales Q2Q%-73.7%
Revenue Next Year-6.4%
Revenue Next 2Y-1.13%
Revenue Next 3Y1.12%
Revenue Next 5Y3.83%
EBIT growth 1Y-49.91%
EBIT growth 3Y-13.99%
EBIT growth 5Y-12.24%
EBIT Next Year48.48%
EBIT Next 3Y19.83%
EBIT Next 5YN/A
FCF growth 1Y-354.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.03%
OCF growth 3YN/A
OCF growth 5YN/A
ACCENDRA HEALTH INC / ACH Fundamental Analysis FAQ
What is the fundamental rating for ACH stock?
ChartMill assigns a fundamental rating of 3 / 10 to ACH.
Can you provide the valuation status for ACCENDRA HEALTH INC?
ChartMill assigns a valuation rating of 6 / 10 to ACCENDRA HEALTH INC (ACH). This can be considered as Fairly Valued.
What is the profitability of ACH stock?
ACCENDRA HEALTH INC (ACH) has a profitability rating of 4 / 10.
Can you provide the financial health for ACH stock?
The financial health rating of ACCENDRA HEALTH INC (ACH) is 1 / 10.
Is the dividend of ACCENDRA HEALTH INC sustainable?
The dividend rating of ACCENDRA HEALTH INC (ACH) is 0 / 10 and the dividend payout ratio is 0%.